Hillstar Bio

Hillstar Bio develops next-generation precision immunology therapies for autoimmune diseases. Their approach selectively depletes pathogenic immune cells while preserving healthy ones, aiming for more durable therapeutic responses than traditional immunosuppressants. The company leverages tailored discovery techniques for each therapeutic.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $67M

Date: 25-Mar-2025

Investors: Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience

Markets: Biotechnology, Immunology, Therapeutics

HQ: Boston, Massachusetts, United States

Founded: 2023

Website: https://www.hillstarbio.com/

LinkedIn: https://www.linkedin.com/company/hillstar-bio/

Twitter:

Instagram: